Middle East and Africa Medical Cannabis Market Size, Share & Trends Analysis Report By Product Type (Flowers, Concentrates, Topicals & Transdermal Formulations, Oils & Tinctures, Other Product Types), By Application (Oncology, Chronic Pain Management, Mental Health Management, Neurological Disease Management, Other Applications), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Country (UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of MEA) Forecasts, 2026-2036

Market Overview

The Middle East and Africa Medical Cannabis Market size was valued at USD 0.7 billion in 2025 and is projected to grow from USD 0.81 billion in 2026 to reach USD 2.62 billion by 2034, growing at a CAGR of 16.3% during the forecast period 2026–2034.

Medical cannabis, also known as medical marijuana, is a herbal medication derived from Cannabis plants used to treat specific symptoms or diseases, such as cancer, chronic pain, and psychiatric disorders. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main cannabinoids extracted from this plant that provide medicinal benefits.

It is anticipated that the advancement of medicinal cannabis will fuel the development of this industry over the coming years through clinical trials and judgments made by regulatory agencies in developed countries. In addition, it is anticipated that over the forecast period, the status of medicinal cannabis will improve because of clinical trials and decisions taken by regulatory agencies in developed countries. But the market is constrained by a dearth of knowledge about the advantages of medical marijuana and strict regulatory requirements.

Middle East and Africa Medical Cannabis Market Segmentation Analysis

By Product Type

The Middle East and Africa Medical Cannabis Market is segmented into Flowers, Concentrates, Topicals & Transdermal Formulations, Oils & Tinctures, and Other Product Types. Flowers include dried cannabis products used for medical purposes where permitted under applicable regulations, while concentrates contain higher concentrations of cannabinoids for selected therapeutic applications. Topicals and transdermal formulations are designed for localized or systemic delivery through the skin, whereas oils and tinctures provide controlled administration and dosing flexibility. Oils & Tinctures represent an important product category because of their convenient administration and suitability for controlled cannabinoid delivery, while increasing development of regulated medical cannabis formulations is supporting product diversification across the region.

Growing interest in cannabis-based therapies, increasing research activities, gradual development of regulatory frameworks, and improvements in extraction and formulation technologies are supporting demand across product categories. Flowers continue to represent a relevant product type in markets where medical use is legally permitted, while concentrates are benefiting from advancements in cannabinoid extraction and standardized formulations. Topical and transdermal products are creating opportunities for localized applications, while oils and tinctures are gaining attention because of their flexible dosing and ease of administration. Continued regulatory development, pharmaceutical research, and increasing awareness of potential therapeutic applications are expected to support further growth across product types.

Request Customizationto receive a tailored report.

By Application

The Middle East and Africa Medical Cannabis Market is segmented into Oncology, Chronic Pain Management, Mental Health Management, Neurological Disease Management, and Other Applications. Oncology applications include supportive management of selected symptoms associated with cancer and its treatment, while chronic pain management represents an important therapeutic area because of the burden of persistent pain conditions. Mental Health Management includes selected applications related to conditions such as anxiety and other disorders, while Neurological Disease Management covers conditions such as epilepsy, multiple sclerosis, and other neurological disorders. Other Applications include additional therapeutic areas where medical cannabis products may be considered under applicable clinical and regulatory frameworks.

Chronic Pain Management represents a significant application area due to the prevalence of persistent pain and growing interest in alternative therapeutic approaches. Oncology applications are also gaining attention for selected treatment-related symptoms, while Neurological Disease Management is supported by increasing research into conditions such as epilepsy and multiple sclerosis. Mental Health Management is developing alongside ongoing research into cannabinoid-based therapies. Increasing clinical research, physician awareness, healthcare development, and gradual acceptance of regulated cannabis-based medicines are expected to support application growth across the Middle East and Africa.

By Distribution Channel

The Middle East and Africa Medical Cannabis Market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies. Hospital pharmacies distribute prescribed medical cannabis products within healthcare institutions and are particularly relevant for physician-supervised treatment and specialized patient care. Drug Stores & Retail Pharmacies provide access to eligible patients in markets where medical cannabis distribution through pharmacies is permitted, while Online Pharmacies offer digital ordering and delivery capabilities where legally authorized. Hospital pharmacies represent an important channel because regulated medical cannabis products require appropriate dispensing, prescription management, and patient guidance.

Drug Stores & Retail Pharmacies can benefit from the development of regulated pharmaceutical distribution networks and increasing availability of approved cannabis-based medicines, while Online Pharmacies may gain opportunities as digital healthcare and e-pharmacy services expand. Hospital pharmacies remain important for specialized and clinically supervised treatments, particularly where medical cannabis is integrated into formal healthcare pathways. Regulatory clarity, improvements in healthcare infrastructure, increasing digitalization of pharmaceutical services, and gradual expansion of prescription-based access are expected to support the development of distribution channels across the Middle East and Africa.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The Middle East and Africa medical cannabis market is expected to grow at a CAGR of 20.4% during the forecast period.

Due to some key issues, like weak rules and lower adoption rates, the Middle East would see the least market growth. Due to rigorous government rules, it is anticipated that the region will only experience limited growth. Due to the negative consequences of cannabis and the illicit use of marijuana, the industry is also anticipated to grow slowly. Few Arab nations in the Middle East have strong rules governing the use and handling of cannabis-related items. As a result, there is little room for market expansion in these areas over the predicted period. 2020 saw Lebanon become the first Arab nation to legalize cannabis for both medical and industrial purposes.

List of Key and Emerging Players in Middle East and Africa Medical Cannabis Market